Jennewein Biotechnologie GmbH

RHEINBREITBACH, Germany, August 29, 2011 - -License Agreement Provides Rights to Pfizer Nutrition for Innovative, Biologically-SourcedHuman Milk Components Jennewein Biotechnologie today announced that the company has signed a license agreement with Pfizer Nutrition to develop and market two Human Milk Oligosaccharides (HMOs).

BONN and RHEINBREITBACH, Germany - Human milk oligosaccharides - an important ingredient in human breast milk - play a central role in protecting infants against infection.